glp-1 with the least amount of side effects A monthly dose could cut number shots patients take each year from 52 to 12. from the drug — mainly gastrointestinal symptoms — were similar to or GLP-1 medications have changed the

Initial concerns that participants could lose weight when taking the drug turned out to be unfounded

Compounded therapy may have a role in certain situations, but it should not be treated as casually interchangeable with an approved drug

Medical use: Despite early research into sleep and hormone regulation, DSIP has not been adopted into mainstream clinical practice

Heart Failure with Preserved Ejection Fraction and Metabolic Comorbidities The evidence most strongly supports the use of GLP-1RAs in the metabolic phenotype of HFpEF with NYHA Class IIIV symptoms, defined by obesity (BMI 30 kg/m 2 ) with or without T2D